Skip to main content

Table 1 Characteristics of 658 patients treated between 1993–2010 for rectal cancer at the University hospital of Wuerzburg

From: Multimodal therapy in treatment of rectal cancer is associated with improved survival and reduced local recurrence - a retrospective analysis over two decades

Characteristic 1993-2001 (n=301) 2002..2010 (n=357) p-value
No. % No. %
Sex      0.035
Male 182   244
Female 119   113
Age, years    n.s.
Median 66.16 (+/−11.88) 66.83 (+/−11.5)
Range 22.06-93.6 27.7-93.6
pUICC      
0 0 0 15 4.2 <0.0001
I 95 28.6 127 35.6 n.s.
II 58 19.3 67 18.8 n.s.
III 62 20.6 79 22.1 n.s.
IV 67 22.3 64 17.9 n.s.
X 19 6.3 5 1.4 <0.001
cUICC      
I 81 26.9 79 22.1 n.s.
II 75 24.9 69 19.3 n.s.
III 67 22.3 135 37.8 <0.001
IV 66 21.9 69 19.3 n.s.
X 12 4 5 1.4 0.037
Patho. T-stage      
pT0 0 0 18 5 <0.001
pT 1,2 118 39.2 163 45.7 n.s.
pT3 124 41.2 129 36.1 n.s.
pT4 29 9.6 13 3.6 0.002
pTx 30 10 30 8.4 n.s.
pTis 0 0 3 0.8 n.s.
Patho. N-stage      
pN0 149 49.5 216 60.5 0.005
pN1 52 17.3 65 18.2 n.s.
pN2 61 20.2 38 10.6 <0.001
pNx 39 13 37 10.4 n.s.
Distance to anal verge      
<4cm 59 19.6 121 33.9 <0.001
4-8cm 96 31.9 129 36.1 n.s.
8-12cm 104 34.6 81 22.7 <0.001
>12cm 36 12 24 6.7 0.02
x 6 2 1 0.5 0.033
Clinical T-stage      
cT1,2 95 31.6 81 22.7 0.01
cT3,4 179 59.5 248 69.5 0.007
cTx 27 9 28 7.8 n.s.
Clinical N-stage      
N0 140 46.5 128 35.9 0.006
cN+ 91 30.3 182 51 <0.001
cNx 70 23.2 47 13.2 <0.001